Target intelligence / Profile preview

Human papillomavirus type 11 major capsid protein L1 (HPV-11 L1)

Target
HPV-11 L1
Molecular classification
Viral protein, Other
01

Overview

Human papillomavirus type 11 major capsid protein L1 (HPV-11 L1) is the primary structural protein of the HPV-11 viral capsid, which encapsulates the viral double-stranded DNA genome. The L1 protein self-assembles into pentameric capsomeres, 72 of which form the icosahedral capsid of the virion. Biologically, HPV-11 L1 mediates the initial attachment of the virus to host cell surfaces by binding to heparan sulfate proteoglycans on basal layer keratinocytes, initiating a conformational change that facilitates viral entry via endocytosis. HPV-11 is a low-risk human papillomavirus type primarily associated with benign epithelial lesions, most notably genital warts (condylomata acuminata) and recurrent respiratory papillomatosis. Recombinant HPV-11 L1 proteins are capable of spontaneously assembling into non-infectious virus-like particles (VLPs) that retain the native antigenicity of the virion. These VLPs serve as the active antigenic components in prophylactic vaccines, such as the quadrivalent (Gardasil) and 9-valent (Gardasil 9) HPV vaccines. Vaccination with these VLPs induces a robust, type-specific neutralizing antibody response that prevents subsequent HPV-11 infection and its associated clinical manifestations.

Other names
Major capsid protein L1HPV-11 L1 proteinHPV11 L1Human papillomavirus 11 major capsid protein L1VL1_HPV11
02

Mechanism of action

Active immunization by inducing neutralizing antibodies against HPV-11 L1, preventing viral attachment and entry into host cells

03

Biological functions

Viral attachment to host cellViral entry into host cellImmune responseOther
04

Disease associations

InfectionOther
05

Safety considerations

Injection site reactions (pain, swelling, erythema)Systemic adverse events (fever, headache, fatigue, nausea)SyncopeHypersensitivity reactions
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

Anti-HPV-11 L1 antibody titerHPV-11 DNA

Beyond the preview

Go deeper on Human papillomavirus type 11 major capsid protein L1 (HPV-11 L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human papillomavirus type 11 major capsid protein L1 (HPV-11 L1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call